TLRY stock icon

Tilray
TLRY

$1.62
2.98%

Market Cap: $1.37B

 

About: Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Employees: 2,650

0
Funds holding %
of 6,686 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

24% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 78

9% less call options, than puts

Call options by funds: $16.9M | Put options by funds: $18.5M

1% less funds holding

Funds holding: 352 [Q1] → 347 (-5) [Q2]

1.97% less ownership

Funds ownership: 11.88% [Q1] → 9.91% (-1.97%) [Q2]

10% less first-time investments, than exits

New positions opened: 45 | Existing positions closed: 50

37% less capital invested

Capital invested by funds: $218M [Q1] → $137M (-$81.5M) [Q2]

Research analyst outlook

We haven’t received any recent analyst ratings for TLRY.

Financial journalist opinion

Based on 34 articles about TLRY published over the past 30 days